Tag: survival

PARIS, FRANCE, 24 July 2025 - Ipsen announced today that the European Commission has approved Cabometyx^® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated pancreatic (pNET) and extra-pancreatic (epNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues.

Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial evaluating its monoclonal antibody, procizumab, in patients with shock caused primarily by cardiogenic events. Shock is a life-threatening condition characterized by a sudden breakdown in circulatory function due to end-stage disease or acute events, which often leads to organ failure. With only symptomatic treatment options available, shock is associated with a high mortality rate of over 50%. The Phase 1b/2a trial is designed to identify a target dose for procizumab in preparation for further clinical development. In addition, the trial will provide signals of efficacy. In a Phase 1 study in healthy volunteers, procizumab was well tolerated.

ORION CORPORATION
PRESS RELEASE
21 JULY 2025 at 10:30 EEST          

ORION OYJ
LEHDISTÖTIEDOTE
21.7.2025 klo 10.30

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses IRobot (IRBT) To Contact Him Directly To Discuss Their Options

Gulfport, Florida , July 19, 2025 (GLOBE NEWSWIRE) -- Airenteed Heating and Cooling, a locally trusted HVAC company, is playing a vital role in restoring comfort and safety to a senior residential community in Gulfport, Florida, following the damage caused by last summer’s devastating hurricane. The 55-and-older community had been left without functioning air conditioning for nearly a year, leading to uncomfortable and often dangerous living conditions during Florida’s hottest months. Now, thanks to the efforts of Airenteed, that’s finally changing.